Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

L&g Enhancedcom (ENCO)

L&g Enhancedcom
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ENCO
DateTimeSourceHeadlineSymbolCompany
09/09/200913:30PR Newswire (US)Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial WLSE:ENCO
31/08/200922:31PR Newswire (US)Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' EquityLSE:ENCO
27/08/200922:12PR Newswire (US)Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q FilingLSE:ENCO
01/07/200914:10PR Newswire (US)Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. BusinessLSE:ENCO
01/07/200914:10PR Newswire (US)Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. BusinessLSE:ENCO
19/05/200921:37PR Newswire (US)Encorium Reports First Quarter 2009 Financial ResultsLSE:ENCO
18/05/200921:05PR Newswire (US)Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. BusinessLSE:ENCO
07/05/200920:23PR Newswire (US)Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research TeamLSE:ENCO
06/10/200812:50PR Newswire (US)Encorium Announces Stock Buyback; Provides Business and Financial UpdateLSE:ENCO
01/10/200821:12PR Newswire (US)Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee RequiremLSE:ENCO
 Showing the most relevant articles for your search:LSE:ENCO

Your Recent History

Delayed Upgrade Clock